Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001509008-11-000001
Filing Date
2011-01-05
Accepted
2011-01-04 20:56:06
Documents
1
Effectiveness Date
2011-01-05
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8495
  Complete submission text file 0001509008-11-000001.txt   9968
Mailing Address 1823 K STREET, NW SUITE 520 WASHINGTON DC 20006
Business Address 1823 K STREET, NW SUITE 520 WASHINGTON DC 20006 202-223-7002
Chase Pharmaceuticals Corp (Filer) CIK: 0001509008 (see all company filings)

EIN.: 208866868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-153008 | Film No.: 11508741